January 2025 Penny Stocks To Watch For Growth

As the U.S. stock market experiences a surge, with major indexes like the Dow Jones and S&P 500 on track for significant weekly gains, investors are keenly observing potential opportunities beyond large-cap stocks. Penny stocks, often associated with smaller or newer companies, remain an intriguing area for those looking to explore investment possibilities outside mainstream options. Despite being considered an outdated term by some, penny stocks continue to offer unique prospects when they demonstrate financial robustness and growth potential.

Top 10 Penny Stocks In The United States
Name Share Price Market Cap Financial Health Rating
QuantaSing Group (NasdaqGM:QSG) $3.08 $91.49M ★★★★★★
BAB (OTCPK:BABB) $0.884275 $6.54M ★★★★★★
Kiora Pharmaceuticals (NasdaqCM:KPRX) $3.50 $10.2M ★★★★★★
Inter & Co (NasdaqGS:INTR) $4.65 $2B ★★★★☆☆
ZTEST Electronics (OTCPK:ZTST.F) $0.285 $11.23M ★★★★★★
Golden Growers Cooperative (OTCPK:GGRO.U) $4.50 $67.38M ★★★★★★
BTCS (NasdaqCM:BTCS) $2.68 $48.23M ★★★★★★
Smith Micro Software (NasdaqCM:SMSI) $1.13 $20.22M ★★★★★☆
CBAK Energy Technology (NasdaqCM:CBAT) $0.908 $82.23M ★★★★★☆
Safe Bulkers (NYSE:SB) $3.41 $380.13M ★★★★☆☆

Click here to see the full list of 713 stocks from our US Penny Stocks screener.
Let's explore several standout options from the results in the screener.
Freightos (NasdaqCM:CRGO)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Freightos Limited operates a vendor-neutral booking and payment platform for international freight, with a market cap of $162.88 million.
Operations: Freightos Limited has not reported any specific revenue segments.
Market Cap: $162.88M
Freightos Limited, with a market cap of US$162.88 million, has shown promising revenue growth despite being unprofitable. Recent earnings guidance for Q4 2024 indicates revenue between US$6.4 million and US$6.5 million, reflecting a year-over-year increase of 21% to 24%. The company reported sales of US$6.19 million in Q3 2024, up from US$5.11 million the previous year, while net losses decreased significantly to US$2.72 million from US$7.16 million year-over-year. Freightos remains debt-free and maintains a strong cash runway exceeding three years, supported by strategic partnerships like its integration with e2open's TMS application for enhanced air cargo booking efficiency.
Dive into the specifics of Freightos here with our thorough balance sheet health report.
Review our growth performance report to gain insights into Freightos' future.
NasdaqCM:CRGO Debt to Equity History and Analysis as at Jan 2025
Chimerix (NasdaqGM:CMRX)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Chimerix, Inc. is a biopharmaceutical company focused on developing medicines to improve and extend the lives of patients with deadly diseases, with a market cap of $312.08 million.
Operations: The company's revenue segment is derived entirely from its Pharmaceuticals business, totaling $0.159 million.
Market Cap: $312.08M
Chimerix, Inc., with a market cap of US$312.08 million, is pre-revenue and focuses on developing treatments for life-threatening diseases. Despite being unprofitable, the company has managed to reduce losses by 20.7% annually over the past five years and maintains a stable cash runway exceeding one year. Recent developments include submitting a New Drug Application to the FDA for dordaviprone, aiming for accelerated approval with potential priority review status. Chimerix remains debt-free but recently secured a US$30 million credit facility from Silicon Valley Bank, providing financial flexibility without immediate borrowing obligations.
Take a closer look at Chimerix's potential here in our financial health report.
Evaluate Chimerix's prospects by accessing our earnings growth report.
NasdaqGM:CMRX Debt to Equity History and Analysis as at Jan 2025
Healthier Choices Management (OTCPK:HCMC)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Healthier Choices Management Corp. operates natural and organic retail stores in the United States with a market cap of $481,266.
Operations: The company generates revenue from its vapor segment, which amounts to $0.000923 million.
Market Cap: $481.27k
Healthier Choices Management Corp., with a market cap of US$481,266, is pre-revenue and faces significant financial challenges. The company reported minimal sales of US$0.000052 million for the third quarter of 2024, alongside a net loss of US$4.35 million, up from the previous year's loss. Despite having more cash than total debt and short-term assets exceeding liabilities, HCMC's debt-to-equity ratio has worsened over five years. The management team is experienced with an average tenure of 9.4 years but operates under high share price volatility and declining earnings over the past five years at a rate of 45.6% annually.
Navigate through the intricacies of Healthier Choices Management with our comprehensive balance sheet health report here.
Gain insights into Healthier Choices Management's historical outcomes by reviewing our past results report.
As the U.S. stock market experiences a surge, with major indexes like the Dow Jones and S&P 500 on track for significant weekly gains, investors are keenly observing potential opportunities beyond large-cap stocks. Penny stocks, often associated with smaller or newer companies, remain an intriguing area for those looking to explore investment possibilities outside mainstream options. Despite being considered an outdated term by some, penny stocks continue to offer unique prospects when they demonstrate financial robustness and growth potential.